Published in Lancet on May 30, 1981
Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ (1989) 1.73
Cancer risk following pernicious anaemia. Br J Cancer (1989) 1.50
Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol (2010) 1.48
The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Science (2014) 1.37
Melanoma in immunosuppressed patients. Mayo Clin Proc (2012) 1.07
Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer (2003) 1.02
Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review. Med Oncol (2009) 0.88
Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. J Clin Oncol (2015) 0.80
Melanomas in renal transplant recipients: the London experience, and invitation to participate in a European study. Br J Dermatol (2007) 0.79
On the clinical significance of cutaneous melanoma's precursors. Indian Dermatol Online J (2012) 0.79
Effect of Medications on Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Population-Based Cohort Study from Olmsted County, Minnesota. Mayo Clin Proc (2015) 0.78
Cancer in organ transplant recipients: part of an induced immune deficiency syndrome. Br Med J (Clin Res Ed) (1984) 0.77
Melanoma in organ transplant recipients: incidence, outcomes and management considerations. J Skin Cancer (2012) 0.75
Dermatology-important advances in clinical medicine: dysplastic nevus syndrome. West J Med (1983) 0.75
Donor transmission of melanoma following renal transplant. Case Rep Transplant (2012) 0.75
The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res (1969) 13.27
Germline p16 mutations in familial melanoma. Nat Genet (1994) 5.59
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med (1995) 4.10
THE CLINICAL EVALUATION OF AUREOMYCIN. J Clin Invest (1949) 3.60
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol (1978) 2.81
The classification of malignant melanoma and its histologic reporting. Cancer (1973) 2.67
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA (1997) 2.65
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst (1998) 2.53
Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol (1975) 2.36
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet (2005) 2.13
Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer (1980) 2.04
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
The developmental biology of primary human malignant melanomas. Semin Oncol (1975) 1.92
Premarital sex, schoolgirl pregnancy, and school quality in rural Kenya. Stud Fam Plann (2001) 1.91
Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg (1983) 1.89
Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res (1985) 1.85
Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA (1978) 1.74
The dynamics of a heroin addiction epidemic. Science (1973) 1.74
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A (1983) 1.72
Lentigo maligna and lentigo-maligna melanoma. Am J Pathol (1969) 1.68
The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med (1971) 1.65
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
The dysplastic nevus syndrome: our definition. Am J Dermatopathol (1982) 1.63
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann Intern Med (1996) 1.62
Biology of tumor progression in human melanocytes. Lab Invest (1987) 1.61
Amyl nitrite may alter T lymphocytes in homosexual men. Lancet (1982) 1.54
Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. J Natl Cancer Inst (1984) 1.54
Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism. J Natl Cancer Inst (1978) 1.53
High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med (1985) 1.51
The biologic forms of malignant melanoma. Hum Pathol (1986) 1.51
Primary malignant melanoma of the urinary bladder. Cancer (1976) 1.48
Early melanoma. Histologic terms. Am J Dermatopathol (1991) 1.43
Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy. Am J Hum Genet (1986) 1.39
Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies. Hum Pathol (1973) 1.36
How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol (1986) 1.34
Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet (1986) 1.34
Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet (1982) 1.31
Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. N Engl J Med (1982) 1.29
Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. Cancer Res (1980) 1.27
A fine-structure study of the human epidermal melanosome complex and its acid phosphatase activity. J Ultrastruct Res (1968) 1.26
Familial and sporadic Hodgkin's disease associated with occupational wood exposure. Lancet (1978) 1.26
Radiogenic male breast cancer with in vitro sensitivity to ionizing radiation and bleomycin. Cancer Invest (1983) 1.24
Melphalan may be a more potent leukemogen than cyclophosphamide. Ann Intern Med (1986) 1.23
Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. J Natl Cancer Inst (1989) 1.23
Evidence against Ha-ras-1 involvement in sporadic and familial melanoma. Nature (1987) 1.21
Malignant melanoma in the Sinclair miniature swine: an autopsy study of 60 cases. Am J Pathol (1979) 1.18
Progressive arterial occlusive disease (Köhlmeier-Degos). A frequently fatal cutaneosystemic disorder. N Engl J Med (1967) 1.17
Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet (1984) 1.15
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N Engl J Med (1983) 1.12
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet (1980) 1.12
Mycosis fungoides: epidemiologic observations. Cancer Treat Rep (1979) 1.11
Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol (1984) 1.11
Reactivity of monoclonal anti-melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma. Eur J Immunol (1979) 1.10
Cancer mortality among printing plant workers. Environ Res (1979) 1.10
Impact of the Sahelian drought in Mauritania, West Africa. Lancet (1974) 1.10
Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am J Hum Genet (1993) 1.08
Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res (1989) 1.07
Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. Br J Cancer (2008) 1.05
Expression of DR antigens in freshly frozen human tumors. Hybridoma (1982) 1.05
Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases. Cancer (1975) 1.05
Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study. Public Health Genomics (2010) 1.05
NIH conference. A multidisciplinary approach to non-hodgkin's lymphomas. Ann Intern Med (1981) 1.04
The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol (1993) 1.03
Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia. Cancer Genet Cytogenet (1988) 1.03
An outbreak of varicella-zoster virus infection among cancer patients. Ann Intern Med (1980) 1.03
Cancer trends in a population at risk of acquired immunodeficiency syndrome. J Natl Cancer Inst (1985) 1.02
Dysplastic naevi and cutaneous melanoma risk. Lancet (1983) 0.99
The clinical diagnosis of malignant melanoma. Semin Oncol (1975) 0.98
Relationship between patients' early recognition of melanoma and depth of invasion. Cancer (1982) 0.98
Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. Natl Cancer Inst Monogr (1985) 0.98
Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr (1983) 0.98
Disorders of the panniculus adiposus. Hum Pathol (1973) 0.98
Malignant melanoma simulants arising in congenital melanocytic nevi do not show experimental evidence for a malignant phenotype. Am J Pathol (1990) 0.97
Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol (1990) 0.97
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med (1987) 0.97
A t(1;19) chromosome translocation in three cases of human malignant melanoma. Cancer Res (1986) 0.97
Molecular phylogeny and biogeography of the marine shrimp Penaeus. Mol Phylogenet Evol (1998) 0.96
Production and characterization of monoclonal antibodies against human malignant melanoma. Cancer Invest (1983) 0.96
Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. Cancer Res (1983) 0.96
The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg (1991) 0.96
Current concepts of the biology of human cutaneous malignant melanoma. Adv Cancer Res (1977) 0.95
Comparison of the classification by microscopic level (stage) of malignant melanoma by three independent groups of pathologists. Cancer (1977) 0.94
Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B. N Engl J Med (1986) 0.93
Opiate "overdose" deaths in the District of Columbia. I. Heroin-related fatalities. Med Ann Dist Columbia (1974) 0.93
The epidemiology of ovarian cancer. Semin Oncol (1984) 0.93